:format(jpeg):focal(2067x73:2077x63)/cloudfront-us-east-1.images.arcpublishing.com/gfrmedia/FM6STVHLPBHC5MOHKD5SHRGTFU.jpg)
saint Louis — JC Mejia, right-handed pitcher for the Milwaukee Brewers, was suspended for 162 games by the Major Leagues on Wednesday, after giving his second positive result for the consumption of a substance that enhances sports performance.
The 27-year-old Dominican tested positive for stanozolol and became the first player suspended under the terms of Major League Baseball’s drug settlement since his compatriot Fernando Tatis, of the San Diego Padres, finished serving an 80-game suspension on August 12 of last year.
Mejia was suspended 80 games on May 17, 2022, after his first positive test for stanozolol, a synthetic steroid derived from testosterone.
“The Milwaukee Brewers fully support Major League Baseball’s Joint Program for the Prevention and Treatment of Drug Abuse, and share the goal of eliminating performance-enhancing substances from our sport,” said the Milwaukee Brewers’ president of baseball operations. Brewers, Matt Arnold, in a statement.
Mejia has been on the injured list since August 15, due to inflammation in his right shoulder. He was transferred to the 60-day injured list on September 11.
He was 1-0 with a 5.56 ERA in nine appearances this season. He struck out 13 and walked three in 11 1/3 innings.
The Dominican is in his third season in the Majors. He has an 8.32 ERA in 28 games over his major league career.
Thirteen players have been suspended this season under Major League Baseball’s anti-drug program.
Seven players were suspended the previous year for the same reason.
